Monday’s stock market has experienced a variety of intra-day movements, with significant activity in both the mega-cap and large-cap categories. Stocks such as NVIDIA (NASDAQ:NVDA), Applovin (APP) and Boeing Co (NYSE:BA) have seen notable increases, while Cigna Corp (NYSE:CI) and Diamond Eagle Acquisition Corp (DKNG) have faced declines. Here’s an overview of some of the most impactful stock movers, spanning from mega-caps to small caps.
Mega-Cap Movers:
NVIDIA (NVDA): +1.9%; sees continued momentum on AI gainsLarge-Cap Stock Movers:
Applovin (APP); BofA raises price target to $210; +8.24% Boeing Co (BA); Emirates SkyCargo to Expand Fleet, Capacity with Five More Boeing 777 Freighters; +4.14% Kenvue Inc (NYSE:KVUE); Starboard Value Builds Stake In Tylenol-Maker Kenvue – WSJ; +6.56% Ritchie Bros. Auctioneers (NYSE:RBA); +6.18% Marvell (NASDAQ:MRVL) Technology Group Ltd (MRVL); +3.41% Cigna Corp (CI); falls on report it is in talks again to merge with Huana (HUM); -4.16% DraftKings (NASDAQ:DKNG); -4.11% Monolithic Power (NASDAQ:MPWR); -3.52%Mid-Cap Stock Movers:
Oklo (OKLO); sees continued momentum on big tech’s nuclear ambitions; +9.24% Construction Partners Inc (NASDAQ:ROAD); CPI announces acquisition of Lone Star Paving for $654 million; +12.22% Ikonics Corp (WULF); +10.4% Alkami Technology (ALKT); +5.94% Ibotta (IBTA); +5.94% Neumora Therapeutics (NMRA); -14.55% VF Corp (NYSE:VFC); JP Morgan adds to negative catalyst watch; -6.76% Avidity Biosciences Inc (RNA); -7.64%Small-Cap Stock Movers:
Nano Nuclear Energy (NNE); sees continued momentum on big tech’s nuclear ambitions; +16.09% Viad Corp (NYSE:VVI); Viad to sell GES unit for $535 million, to become Pursuit; +15.29% Ehang Holdings Ltd (NASDAQ:EH); +14.3% Audioeye, Inc (AEYE); +12.05% European Biotech Acquisition (OCS); Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees; +10.66% HPX (AMBI); +7.74% Alpha Teknova (TKNO); -7.0%For real-time, market-moving news, join Investing Pro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.